NCT03413683 Frailty in Older HIV-infected Individuals
| NCT ID | NCT03413683 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | HIV Infections |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2018-04-01 |
| Primary Completion | 2028-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2018-04-01 with a primary completion date of 2028-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Frailty has been proposed as a measure of biological (as opposed to chronological) aging. In this study the investigators plan to: (1) measure frailty in a cohort of older HIV-infected individuals in Hong Kong, and its association with mortality and quality of life; (2) identify risk factors predictive of development of frailty in HIV-infected individuals in Hong Kong; and (3) determine the outcomes of HIV-infected individuals in Hong Kong with and without frailty. The following assessment will be done: 1. Physical examination including measuring height, weight, hip and waist circumference. 2. Grip strength, chair stand test, gait speed test, balance tests, and neurocognitive tests 3. Geriatric syndromes, screening for depression, disability and quality of life. 4. Blood tests during fasting state to measure metabolic parameters. This is a prospective longitudinal observational study that lasts for 10 years.
Eligibility Criteria
Inclusion Criteria: * HIV infection with positive anti-HIV antibody * Age ≥50 years Exclusion Criteria: * Refuses to consent
Contact & Investigator
Grace Lui
PRINCIPAL INVESTIGATOR
CUHK
Frequently Asked Questions
Who can join the NCT03413683 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying HIV Infections. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03413683 currently recruiting?
Yes, NCT03413683 is actively recruiting participants. Contact the research team at ritywong@cuhk.edu.hk for enrollment information.
Where is the NCT03413683 trial being conducted?
This trial is being conducted at Shatin, Hong Kong.
Who is sponsoring the NCT03413683 clinical trial?
NCT03413683 is sponsored by Chinese University of Hong Kong. The principal investigator is Grace Lui at CUHK. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.